Please login to the form below
cobicistat
This page shows the latest cobicistat news and features for those working in and with pharma, biotech and healthcare.
Positive trial results for Janssen’s Symtuza boosts its HIV credentials
The STR provided ‘effective’and ‘durable’viral suppression. Janssen’s darunavir-based single tablet regimen (STR) Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide) showed a positive outcome in the treatment of HIV
Latest news
-
Janssen wins European approval for Symtuza
It’s the first complete, single-tablet regimen (STR) based on its big-selling protease inhibitor Prezista (darunavir), which it combines with cobicistat, emtricitabine and tenofovir alafenamide (TAF).
-
CHMP backs three immuno-oncology drugs for solid tumours
The once-daily product combines darunavir with cobicistat, emtricitabine and tenofovir alafenamide (TAF) and is vying to compete with therapies from GlaxoSmithKline's ViiV unit.
-
Gilead plans fightback against HIV arch-rival ViiV
its Genvoya and Stribild products - which needs to be boosted with cobicistat.
-
ViiV takes two-drug cocktail for first-line HIV into phase III
HIV therapies that combine multiple drugs into one tablet such as ViiV's Triumeq (dolutegravir/abacavir/lamivudine) and Gilead's Quad product (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) are expected to be
-
Gilead gets EU nod for TAF-based triple therapy for HIV
also bagged approval for four-drug Genvoya (elvitegravir, emtricitabine, cobicistat and TAF), an updated version of the company's $1.8bn Stribild brand.
More from news
Approximately 7 fully matching, plus 31 partially matching documents found.
Featured jobs
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
-
Associate Scientific Director
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Director or Senior Account Director
-
Salary TBC
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Account Manager
-
Negotiable
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Sudler London - Account Director
-
Competitive
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
Subscribe to our email news alerts
- Boehringer’s Corsico to be new GSK drug dev leader
- More tell, less sell: HCP-centric comms
- Anna Korving to step down as Chair of Communiqué Awards judging panel
- Double win for Pegasus at the Communique awards 2018
- CRUK forges £30m ‘post-Brexit’ R&D alliance
- Nurturing the growth mindset: The need for ongoing professional development in strategic medical communications
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
